Evaluation of airway function and inflammation after theophylline controlled release tablet combined with β2 receptor agonist treatment of bronchial asthma

Clicks: 396
ID: 38317
2016
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #2 of 2 articles by views in journal of hainan medical university

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Objective: To study the effect of theophylline controlled release tablet combined with β2 receptor agonist therapy on airway function and inflammation in patients with bronchial asthma. Methods: A total of 112 patients with bronchial asthma treated in our hospital between June 2014 and December 2015 were selected as the research subjects and randomly divided into two groups: observation group received corticosteroid for anti-inflammation and theophylline controlled release tablet combined with β2 receptor agonist for airway dilation, and control group received glucocorticoid for anti-inflammation and β2 receptor agonist for airway dilation. After 8 weeks of treatment, airway function, signal pathway molecule and cytokine content in serum as well as immune cell content in peripheral blood were determined. Results: After 8 weeks of treatment, VT, FEV1 and PEF levels of observation group were significantly higher than those of control group while FeNO content was significantly lower than that of control group; serum TLR2, MyD88, JNK, IL-4 and IL-5 content of observation group were significantly lower than those of control group while IFN-γ, IL-2, IL-10 and TGF-β content were significantly higher than those of control group; CD4+IFNγ+Th1 cell and CD4+CD25+Foxp3+Treg cell content in peripheral blood of observation group were significantly higher than those of control group while CD4+IL-4+Th2 cell content was significantly lower than that of control group. Conclusions: Theophylline controlled release tablet combined with β2 receptor agonist therapy can improve the airway function in patients with bronchial asthma and reduce the TLR2-mediated inflammation as well as T lymphocyte subset dysfunction.
Reference Key
hu2016evaluationjournal Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal journal of hainan medical university
Year 2016
DOI
DOI not found
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.